BCWORLD PHARM Full Year 2023 Earnings EPS 312 - Simply Wall St
| 200780 Stock | KRW 4,735 10.00 0.21% |
About 54% of BCWORLD PHARM's investor base is interested to short. The analysis of current outlook of investing in BCWORLD PHARM Co suggests that many traders are impartial regarding BCWORLD PHARM's prospects. The current market sentiment, together with BCWORLD PHARM's historical and current headlines, can help investors time the market. In addition, many technical investors use BCWORLD PHARM stock news signals to limit their universe of possible portfolio assets.
BCWORLD |
BCWORLD PHARM Full Year 2023 Earnings EPS 312 Simply Wall St
Read at news.google.com
 |
BCWORLD PHARM Fundamental Analysis
We analyze BCWORLD PHARM's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BCWORLD PHARM using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BCWORLD PHARM based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
BCWORLD PHARM is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
BCWORLD PHARM Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BCWORLD PHARM stock to make a market-neutral strategy. Peer analysis of BCWORLD PHARM could also be used in its relative valuation, which is a method of valuing BCWORLD PHARM by comparing valuation metrics with similar companies.
Peers
BCWORLD PHARM Related Equities
| 055550 | Shinhan Financial | 1.76 |
| ||
| 005380 | Hyundai | 1.94 |
| ||
| 005385 | Hyundai | 2.24 |
| ||
| 005387 | Hyundai | 2.59 |
| ||
| 005930 | Samsung Electronics | 2.67 |
| ||
| 005935 | Samsung Electronics | 2.79 |
| ||
| 105560 | KB Financial | 3.16 |
| ||
| 000660 | SK Hynix | 4.17 |
| ||
| 066570 | LG Electronics | 7.13 |
|
Complementary Tools for BCWORLD Stock analysis
When running BCWORLD PHARM's price analysis, check to measure BCWORLD PHARM's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BCWORLD PHARM is operating at the current time. Most of BCWORLD PHARM's value examination focuses on studying past and present price action to predict the probability of BCWORLD PHARM's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BCWORLD PHARM's price. Additionally, you may evaluate how the addition of BCWORLD PHARM to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |